Apellis shares plunge 13% on wider-than-feared Q3 loss, revenue miss By...

Published on 5 Nov 2024 on Investing.com

Apellis shares plunge 13% on wider-than-feared Q3 loss, revenue miss

Read the rest of the article

Start tracking your investments with Statfolio

PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A co...

Insider Monkey · via Yahoo Finance 12 Dec 2024

Apellis Pharmaceuticals (NASDAQ: NASDAQ:APLS) discussed its third-quarter financial performance...

Investing.com 6 Nov 2024

Apellis shares plunge 13% on wider-than-feared Q3 loss, revenue miss

Investing.com 5 Nov 2024

Release Date: November 05, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Apellis Pharmaceuticals Inc (NASDAQ:APLS) is set to release its Q3 2024 earnings on Nov 5, 2024. ...

GuruFocus.com · via Yahoo Finance 4 Nov 2024

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In t...

Insider Monkey · via Yahoo Finance 19 Sep 2024

There's been a notable change in appetite for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shares ...

Simply Wall St. via Yahoo Finance 9 May 2024

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript May 7, 2024 Apellis ...

Insider Monkey via Yahoo Finance 9 May 2024

For the quarter ended March 2024, Apellis Pharmaceuticals, Inc. (APLS) reported revenue of $172.3...

Zacks via Yahoo Finance 8 May 2024

Apellis Pharmaceuticals, Inc. APLS incurred a first-quarter 2024 loss of 54 cents per share, whic...

Zacks via Yahoo Finance 8 May 2024